National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery
Go back to National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac SurgeryCytosorbents Corporation (NASDAQ: CTSO) | Delayed: 0.95 +0.02 (2.15%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.93 | 52 Week High | $7.48 | |||
Open | $0.91 | 52 Week Low | $3.11 | |||
Day High | $0.96 | P/E | N/A | |||
Day Low | $0.94 | EPS | $-0.03 | |||
Volume | 116,409 |